Liqiong Yang

623 citations
39 papers · 358 indexed · h-index 12
Topics
Cancer-related molecular mechanisms research (6 papers)RNA modifications and cancer (6 papers)Gastric Cancer Management and Outcomes (5 papers)
Journals
SHILAP Revista de lepidopterologíaCancer ResearchScientific Reports

In The Last Decade

Liqiong Yang

38 papers receiving 356 citations

Peers

Liqiong Yang
Comparison fields: 5 of 80
  • Molecular Biology 116
  • Oncology 100
  • Cancer Research 75
  • Pulmonary and Respiratory Medicine 69
  • Physiology 49
Replace Takeharu Imai with:
Takeharu Imai Japan
Wilfredo Alejandro González‐Arriagada Chile
Ana Iulia Neagu Romania
Monika Lejman Poland
Qingquan Hua China
Yin Cheng China
Evert van den Broek Netherlands
Dannel Yeo Australia
Chang Li China
Liqiong Yang relative to Takeharu Imai Japan Takeharu Imai's profile →
Citations per field
00.5×3.9×
Takeharu Imai · 1×
Citations per year

Countries citing papers authored by Liqiong Yang

Since Specialization
Citations

This map shows the geographic impact of Liqiong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiong Yang more than expected).

Fields of papers citing papers by Liqiong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqiong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiong Yang. The network helps show where Liqiong Yang may publish in the future.

Co-authorship network of co-authors of Liqiong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Liqiong Yang. A scholar is included among the top collaborators of Liqiong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqiong Yang. Liqiong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 7
4 3
5 1
6 10
7 11
8 10
9 6
10 24
11 43
12 11
13 2
14 26
15 4
16 22
17 12
18 33
19 23
20 2

About Liqiong Yang

Liqiong Yang is a scholar working on Cancer Research, Developmental Biology and Oncology, having authored 39 papers that have together received 358 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Cancer Research (75 citations), Oncology (100 citations) and Pulmonary and Respiratory Medicine (69 citations). Liqiong Yang has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Zhangang Xiao, Miao‐Zhen Qiu, Jing Shen, Fan Xu, Man Luo, Dajun Yang, Xu Wu, Rui‐Hua Xu, Feng‐Hua Wang and Yueshui Zhao. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026